Ignite Creation Date:
2025-12-24 @ 4:44 PM
Ignite Modification Date:
2026-05-08 @ 7:25 PM
Study NCT ID:
NCT00423566
Status:
COMPLETED
Last Update Posted:
2007-01-18
First Post:
2007-01-17
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
A Phase I Study of the Safety and Immunogenicity of a Recombinant MVA Vaccine Encoding a Secreted Antigen From M. Tuberculosis, Antigen 85A, Delivered Intradermally by a Needle Injection in Healthy Volunteers.
Sponsor:
University of Oxford
Organization:
Conditions & Keywords Data
Conditions:
Conditions
| Condition Brief | Condition Text | View |
|---|---|---|
| None | Tuberculosis | View |